rs2280424

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_152269.5(MTRFR):​c.273C>T​(p.Ile91Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.044 in 1,614,058 control chromosomes in the GnomAD database, including 2,622 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 308 hom., cov: 31)
Exomes 𝑓: 0.044 ( 2314 hom. )

Consequence

MTRFR
NM_152269.5 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.150

Publications

15 publications found
Variant links:
Genes affected
MTRFR (HGNC:26784): (mitochondrial translation release factor in rescue) This nuclear gene encodes a mitochondrial matrix protein that appears to contribute to peptide chain termination in the mitochondrial translation machinery. Two different 1 bp deletions (resulting in the same premature stop codon)result in decreased mitochondrial translation, decreased levels of oxidative phosphorylation complexes and encepthalomyopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
CDK2AP1 (HGNC:14002): (cyclin dependent kinase 2 associated protein 1) The protein encoded by this gene is a cyclin-dependent kinase 2 (CDK2) -associated protein which is thought to negatively regulate CDK2 activity by sequestering monomeric CDK2, and targeting CDK2 for proteolysis. This protein was found to also interact with DNA polymerase alpha/primase and mediate the phosphorylation of the large p180 subunit, which suggests a regulatory role in DNA replication during the S-phase of the cell cycle. This protein also forms a core subunit of the nucleosome remodeling and histone deacetylation (NURD) complex that epigenetically regulates embryonic stem cell differentiation. This gene thus plays a role in both cell-cycle and epigenetic regulation. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_152269.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 12-123253947-C-T is Benign according to our data. Variant chr12-123253947-C-T is described in ClinVar as Benign. ClinVar VariationId is 262628.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.244 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152269.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRFR
NM_152269.5
MANE Select
c.273C>Tp.Ile91Ile
synonymous
Exon 2 of 3NP_689482.1Q9H3J6-1
MTRFR
NM_001143905.2
c.273C>Tp.Ile91Ile
synonymous
Exon 2 of 3NP_001137377.1Q9H3J6-1
MTRFR
NM_001194995.1
c.273C>Tp.Ile91Ile
synonymous
Exon 2 of 3NP_001181924.1Q9H3J6-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MTRFR
ENST00000253233.6
TSL:1 MANE Select
c.273C>Tp.Ile91Ile
synonymous
Exon 2 of 3ENSP00000253233.1Q9H3J6-1
MTRFR
ENST00000366329.7
TSL:2
c.273C>Tp.Ile91Ile
synonymous
Exon 2 of 3ENSP00000390647.1Q9H3J6-1
MTRFR
ENST00000429587.2
TSL:2
c.273C>Tp.Ile91Ile
synonymous
Exon 1 of 2ENSP00000391513.2Q9H3J6-1

Frequencies

GnomAD3 genomes
AF:
0.0480
AC:
7309
AN:
152122
Hom.:
308
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0432
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.0551
Gnomad ASJ
AF:
0.0369
Gnomad EAS
AF:
0.255
Gnomad SAS
AF:
0.0491
Gnomad FIN
AF:
0.0251
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0369
Gnomad OTH
AF:
0.0589
GnomAD2 exomes
AF:
0.0574
AC:
14339
AN:
249938
AF XY:
0.0557
show subpopulations
Gnomad AFR exome
AF:
0.0441
Gnomad AMR exome
AF:
0.0627
Gnomad ASJ exome
AF:
0.0366
Gnomad EAS exome
AF:
0.262
Gnomad FIN exome
AF:
0.0265
Gnomad NFE exome
AF:
0.0368
Gnomad OTH exome
AF:
0.0493
GnomAD4 exome
AF:
0.0436
AC:
63741
AN:
1461818
Hom.:
2314
Cov.:
31
AF XY:
0.0438
AC XY:
31856
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0437
AC:
1464
AN:
33480
American (AMR)
AF:
0.0633
AC:
2832
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0372
AC:
971
AN:
26136
East Asian (EAS)
AF:
0.247
AC:
9792
AN:
39696
South Asian (SAS)
AF:
0.0437
AC:
3771
AN:
86252
European-Finnish (FIN)
AF:
0.0278
AC:
1486
AN:
53390
Middle Eastern (MID)
AF:
0.0463
AC:
267
AN:
5762
European-Non Finnish (NFE)
AF:
0.0360
AC:
40020
AN:
1111990
Other (OTH)
AF:
0.0520
AC:
3138
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
3349
6699
10048
13398
16747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1646
3292
4938
6584
8230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0480
AC:
7312
AN:
152240
Hom.:
308
Cov.:
31
AF XY:
0.0491
AC XY:
3655
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0433
AC:
1798
AN:
41538
American (AMR)
AF:
0.0550
AC:
841
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0369
AC:
128
AN:
3472
East Asian (EAS)
AF:
0.256
AC:
1318
AN:
5158
South Asian (SAS)
AF:
0.0489
AC:
236
AN:
4824
European-Finnish (FIN)
AF:
0.0251
AC:
266
AN:
10618
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0369
AC:
2512
AN:
68016
Other (OTH)
AF:
0.0587
AC:
124
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
345
690
1036
1381
1726
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0439
Hom.:
356
Bravo
AF:
0.0534
Asia WGS
AF:
0.148
AC:
511
AN:
3478
EpiCase
AF:
0.0365
EpiControl
AF:
0.0373

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Combined oxidative phosphorylation defect type 7 (1)
-
-
1
not specified (1)
-
-
1
Spastic paraplegia;C3150801:Combined oxidative phosphorylation defect type 7 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
9.8
DANN
Benign
0.74
PhyloP100
-0.15
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2280424;
hg19: chr12-123738494;
COSMIC: COSV53515771;
COSMIC: COSV53515771;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.